y0news
AnalyticsDigestsSourcesTopicsRSSAICrypto

#machine-learning News & Analysis

Coverage of #machine-learning spans 2,608 indexed articles, with 262 pieces published in the last month. Recent discussion shows 55.7% bullish sentiment, though this represents a 5.3 percentage point decline from the previous quarter, suggesting a modest cooling in tone. Research publications dominate the discourse, particularly through arXiv's computer science and AI sections, while conversations frequently center on models and platforms including Llama, Meta, and Gemini. Related coverage tends to intersect with #research, #ai-research, and #llm discussions. Scan the article list below to explore the latest developments and perspectives.

sentiment · last 30d (262 articles) · -5.3pp bullish vs prior 90d
Top sources:arXiv – CS AI · 1922Apple Machine Learning · 14Crypto Briefing · 10MarkTechPost · 8Hugging Face Blog · 6
Most-discussed entities:Llama · 23Meta · 17Gemini · 15GPT-4 · 14GPT-5 · 13
4586 articles
AIBullishTechCrunch – AI · May 266/10
🧠

This startup is betting India’s gig economy can train the world’s robots

Human Archive, a startup founded by UC Berkeley and Stanford researchers, is leveraging India's gig economy to collect real-world physical training data for AI and robotics development. Gig workers wear camera-equipped caps and sensor devices to generate datasets that labs worldwide are competing to obtain.

AIBullishMIT News – AI · May 206/10
🧠

Building AI models that understand chemical principles

Connor Coley is advancing machine learning applications in chemistry to accelerate drug discovery and compound design. This work represents a convergence of AI with pharmaceutical research, enabling computational models to understand and predict chemical behavior more effectively than traditional methods.

Building AI models that understand chemical principles
AIBullishGoogle Research Blog · May 196/10
🧠

Empirical Research Assistance (ERA): From Nature publication to catalyzing Computational Discovery

Empirical Research Assistance (ERA) represents a significant advancement in AI-assisted scientific research, transitioning from academic publication to practical computational discovery tools. The development demonstrates how machine learning can accelerate the research process across scientific disciplines, with implications for both the academic and technology sectors.

Empirical Research Assistance (ERA): From Nature publication to catalyzing Computational Discovery
AIBullishGoogle DeepMind Blog · May 186/10
🧠

Fast-tracking genetic leads to reverse cellular aging

Biologists have leveraged AI Co-Scientist tools to identify novel genetic factors capable of rejuvenating human cells and reversing cellular aging. This breakthrough demonstrates the practical application of AI in accelerating biological research and understanding aging mechanisms at the genetic level.

Fast-tracking genetic leads to reverse cellular aging
AIBullishGoogle DeepMind Blog · May 176/10
🧠

Gemini for Science: AI experiments and tools for a new era of discovery

Google has launched Gemini for Science, a collection of AI-powered tools and experiments designed to accelerate scientific discovery and research across multiple disciplines. The initiative aims to enhance the scale and precision of scientific exploration by leveraging advanced AI capabilities.

🧠 Gemini
AINeutralGoogle DeepMind Blog · May 166/10
🧠

Finding the molecular switches behind new infectious diseases

Clare Bryant leverages Co-Scientist, an AI tool, to identify genetic triggers that drive the emergence and evolution of infectious diseases. This application of artificial intelligence to molecular biology accelerates the discovery process for understanding how pathogens adapt and spread, with potential implications for pandemic preparedness and therapeutic development.

Finding the molecular switches behind new infectious diseases
AINeutralGoogle DeepMind Blog · May 166/10
🧠

Accelerating discovery of liver disease mechanisms

Filippo Menolascina leverages Co-Scientist AI to accelerate the discovery of liver disease mechanisms and identify new treatment options. The research aims to explain why certain existing drugs are effective only for specific patient populations, potentially enabling more personalized therapeutic approaches.

Accelerating discovery of liver disease mechanisms
AINeutralGoogle DeepMind Blog · May 166/10
🧠

Uncovering repurposed medicines to fight liver fibrosis

Stanford researchers are leveraging AI tools called Co-Scientist to accelerate drug discovery for liver fibrosis treatment by identifying existing medicines that could be repurposed for this chronic liver disease. This approach demonstrates how artificial intelligence can streamline the pharmaceutical research process and potentially bring therapies to market faster.

Uncovering repurposed medicines to fight liver fibrosis
← PrevPage 97 of 184Next →